title: Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results.
authors.affiliation: Department of Urology, University of Heidelberg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Pomer
authors.forename: R
authors.initials: R
authors.lastname: Waldherr
authors.forename: K
authors.initials: K
authors.lastname: Möhring
authors.forename: F
authors.initials: F
authors.lastname: Kempter
authors.forename: M
authors.initials: M
authors.lastname: Wiesel
authors.forename: R
authors.initials: R
authors.lastname: Weimer
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D001379:Azathioprine; D011241:Prednisone